Tonghua Dongbao Pharmaceutical Co., Ltd.

シンボルマーク: 600867.SS

SHH

10.3

CNY

今日の市場価格

18.2244
PER（株価収益率
0.0089
PEGレシオ
20.25B
MRK キャップ
0.02%
DIV利回り

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867-SS) 財務諸表

Q: Tonghua Dongbao Pharmaceutical Co., Ltd.600867.SS 総資産とは何ですか？

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

Tonghua Dongbao Pharmaceutical Co., Ltd.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	1159.7	846.5	902	743.7	368	356	336.4	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	18.6	9.5	8.9	28.3	14.3	4.1	19	6.1	9.8	54.1	132.6	161.2	17.1	34.6	0
balance-sheet.row.short-term-investments	55.5	58.5	37	150.4	-73	-58.8	-29.7	-14.7	-16.3	-17.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	916.8	515.4	707.3	623.7	724.2	677.2	605.3	519.3	455.7	480.2	535.1	595.5	712.1	560	618.3	626.4	544.2	515.7	835.4	834.4	969.9	1021.6	850.2	127.5	131.8	0.4	0.2	4.1	5.6	0
balance-sheet.row.inventory	705.3	653.9	537.9	537.6	628.8	901	973.9	1047.9	954.8	629.6	343.8	233	197.8	187.4	170.1	145.6	145.5	140.1	139.8	140.6	126.6	95.9	98.5	73	53.4	35.1	23.9	25.3	13.4	0
balance-sheet.row.other-current-assets	34.5	40.5	15.2	17.4	205.6	339	324.3	406.9	11.2	0.1	12.5	-84.5	-99.9	-79.2	-113.6	-119.4	-89.2	-77.2	-218.5	-248.9	-310.9	-347.8	-220.4	642.3	664.2	526.3	488	258.1	192.1	205.6
balance-sheet.row.total-current-assets	2816.4	2056.4	2162.5	1922.4	1926.6	2273.2	2240	2209.8	1633.9	1311.8	1107.4	868.6	1053.9	731	721.5	671.2	610	587.6	785	740.3	789.7	788.8	734.3	852.6	903.5	694.5	673.4	304.6	245.7	205.6
balance-sheet.row.property-plant-equipment-net	2704.4	2678.4	2392.1	2287.6	2111	1959.7	1873.4	1851.4	1586.9	1279.9	1259.7	1233.2	1087.1	1147.9	1180.2	1226.9	1224.2	1099.5	873.7	807.7	732.1	673.1	622.3	515.2	478.9	387	185.3	174.5	75.7	43.5
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1338.3	1069.1	796.6	608.8	472.6	388.6	193.6	198.7	102	81.8	80.9	69.1	69.5	77.8	84.9	93.3	104.3	94.3	23.9	32	31.2	30.6	34.7	33	72.1	73.2	9.1	9.8	5.6	0
balance-sheet.row.goodwill-and-intangible-assets	1338.3	1069.1	796.6	608.8	472.6	388.6	193.6	198.7	102	81.8	80.9	69.1	69.5	77.8	84.9	98.2	109.2	94.3	23.9	32	31.2	30.6	34.7	33	72.1	73.2	9.1	9.8	5.6	0
balance-sheet.row.long-term-investments	534.2	304	420.9	311.4	428.8	385	368.3	334.3	195.5	246.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	38.6	46.2	42.4	37.7	37.8	36.2	39	44.1	44	35.6	28.4	30.5	21	20.7	20.7	21.6	28.1	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	339.6	596.2	705.6	635.3	373.1	420.6	38.4	36.8	225.8	0.5	218	178.8	145.8	209	244.2	153.4	297.5	185.7	202.3	226.2	242.1	76.1	65.2	68.3	42.9	24	7.5	7	0.5	17.4
balance-sheet.row.total-non-current-assets	4955	4693.9	4357.6	3880.8	3423.3	3190.1	2512.7	2465.2	2154.3	1644.5	1587	1511.5	1323.4	1455.3	1530	1500.1	1659	1379.5	1099.9	1065.9	1005.4	779.8	722.2	616.5	593.9	484.2	201.9	191.3	81.8	60.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.2	0	0	0
balance-sheet.row.total-assets	7771.4	6750.3	6520.1	5803.3	5349.9	5463.3	4752.7	4675	3788.1	2956.2	2694.5	2380.1	2377.3	2186.3	2251.4	2171.3	2269	1967.1	1885	1806.2	1795.1	1568.5	1456.5	1469.1	1497.4	1178.7	875	495.9	327.5	266.5
balance-sheet.row.account-payables	115.9	80.9	75	68.2	69.2	132	61.3	90.5	53.2	52	38.9	30.8	37.8	46.7	40.7	49.5	40.8	43.1	44.4	45.2	40.7	39.7	29.3	28.7	19.9	25	20.5	20.7	13.6	0
balance-sheet.row.short-term-debt	150	-21.1	-7.9	-8.2	125	450	0	430	872.8	310	283	79	93	64	223	321.7	324.1	251.7	337.9	271.5	249.2	3.2	3.2	3.4	45.9	23	1.7	7.3	0	0
balance-sheet.row.tax-payables	52.5	13.2	111.6	55.5	50.9	40	34.7	20.4	11.7	15.5	14.9	-5.5	4.3	20.5	4	8	12.2	33.7	27.1	17.8	8.8	13.5	4.6	-1.4	-1.2	3.8	3.8	3.9	5.4	0
balance-sheet.row.long-term-debt-total	0	2.6	2.6	2.6	2.6	4	0	60	250	298	256.4	238.8	122	266.6	269.1	269.6	270.1	270.1	48.2	99.5	49.5	49.5	0	0	14.3	15	28.6	11.5	0	0
Deferred Revenue Non Current	27.5	28.5	28.7	32.9	33.4	33.7	35	24.2	24.5	24	-211.4	-226.9	-108.9	-252.1	-251.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	243.8	81.2	193.6	140	29.9	69.4	113.7	5.4	2	3.3	16.3	11.8	12.1	9	11.8	6.8	6.5	6.4	2.7	9.4	6.3	3.9	6.5	2.9	0.5	1	0.8	1.1	60.3	23.5
balance-sheet.row.total-non-current-liabilities	7.4	38.7	31.3	35.6	36.3	37.7	40.3	90.7	282.4	335.1	303.2	252.9	136	284.6	303.5	312.9	313.4	315.6	94	100.3	50.9	52	1.7	0	14.4	15	28.6	11.5	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	527.6	200.7	299.9	243.8	341.1	729.1	215.3	729.8	1309.1	795.7	678.2	388.9	299.4	453.7	624.7	737.7	735	691.1	544.2	480.1	393.9	205.5	78	44.1	92.8	249.8	64.7	51.6	73.9	23.5
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1993.6	1993.7	2034	2034	2034	2034	1711.3	1421.9	1135.8	1030.1	931.5	776.2	776.2	575	479.1	368.6	368.6	368.6	324.5	324.5	324.5	324.5	324.5	324.5	324.5	208	208	115.6	92.4	77.8
balance-sheet.row.retained-earnings	3697.4	3025.5	2700.5	1951.1	1531.1	1208.4	1130.3	942.3	819.9	686.3	716.5	708.3	808.8	482.7	320.1	252.8	212.2	110.5	100.3	87.6	167.8	138.5	190	234.5	196.6	170	91.9	73.8	5.7	26.7
balance-sheet.row.accumulated-other-comprehensive-income-loss	1003.4	1188.1	1039.9	863.5	662.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	516.8	336.9	440.4	705.5	772.5	1481.9	1686.3	1575	503.6	421.4	343.2	477.2	461	641.9	793.6	772.4	911.2	754	871.4	867.8	865.9	859.1	857.6	859	850.6	524.9	510.5	255	155.5	138.5
balance-sheet.row.total-stockholders-equity	7211.2	6544.3	6214.9	5554	5000.4	4724.3	4527.9	3939.2	2459.3	2137.7	1991.2	1961.7	2046	1699.6	1592.9	1393.8	1492	1233.1	1296.1	1279.9	1358.2	1322	1372.1	1417.9	1371.6	902.9	810.3	444.4	253.6	243
balance-sheet.row.total-liabilities-and-stockholders-equity	7771.4	6750.3	6520.1	5803.3	5349.9	5463.3	4752.7	4675	3788.1	2956.2	2694.5	2380.1	2377.3	2186.3	2251.4	2171.3	2269	1967.1	1885	1806.2	1795.1	1568.5	1456.5	1469.1	1497.4	1178.7	875	495.9	327.5	266.5
balance-sheet.row.minority-interest	5.1	5.3	5.3	5.5	8.4	10	9.6	6	19.7	22.8	25	29.5	31.9	32.9	33.8	39.8	42	42.9	44.6	46.2	43	41	6.5	7.1	33	26	0	0	0	0
balance-sheet.row.total-equity	7216.3	6549.6	6220.2	5559.5	5008.8	4734.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	589.8	362.5	457.9	461.8	355.8	326.2	338.6	319.6	179.2	228.8	213.4	173	138.9	209	244.2	153.4	297.5	162.3	202.3	226.2	242.1	76.1	65.2	63.9	38.4	21.7	0	0	0.5	0
balance-sheet.row.total-debt	150	2.6	2.6	2.6	125	450	0	490	1122.8	608	539.4	317.8	215	330.6	492.1	591.3	594.1	521.8	386.1	371	298.7	52.7	3.2	3.4	60.2	38	30.3	18.9	0	0
balance-sheet.row.net-debt	-954.2	-785.4	-862.4	-590.7	-243	94	-336.4	254.4	910.6	406.1	323.3	193.2	-29	267.8	445.4	572.6	584.6	512.9	357.7	356.7	294.6	33.7	-2.9	-6.4	6.1	-94.6	-130.9	1.8	-34.6	0

キャッシュフロー計算書

Tonghua Dongbao Pharmaceutical Co., Ltd. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1167.8	1581.8	1308.6	930.3	809.6	838.9	840.1	639.2	490.1	276.5	179.5	59.6	363	173.4	67.7	44.6	75.7	13.3	18	-74.8	38.2	44.4	31	48	71.5	90.7
cash-flows.row.depreciation-and-amortization	207.1	151.2	143.7	154.5	152.8	172	166.5	160.4	130.8	112.8	108.3	107.6	106.7	103.5	89	72.8	69	64	57.9	48.9	46.9	37.9	27.1	26.5	30.9	17.2
cash-flows.row.deferred-income-tax	7.5	3.7	-4.7	0.2	-1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-863.7	34.1	47.7	3.5	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-449.5	72.6	-48.4	82.7	96.8	-34.7	-65	-140.3	-332	-228.2	-88.5	-59	-156.9	3.6	-33.1	-62.8	-1.1	68	1.8	-62.9	-44.5	-41.7	59.3	-46.3	-197.8	-314.4
cash-flows.row.account-receivables	-430.9	140.6	-97.7	2.3	-43.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-55.5	-124.7	-3.4	97.3	269.7	73.7	71.9	-99.4	-330.1	-287	-110.4	-28.6	-3.3	-17.3	-31.5	-0.1	-5.4	-0.3	0.8	-14	-30.7	2.6	-25.5	-24.7	-18.3	-11.1
cash-flows.row.account-payables	37	52.9	57.5	-17.1	-128.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	3.7	-4.7	0.2	-1.3	-108.4	-136.9	-40.9	-2	58.7	21.9	-30.4	-153.6	20.9	-1.6	-62.7	4.2	68.4	1	-48.9	-13.9	-44.3	84.8	-21.7	-179.4	-303.2
cash-flows.row.other-non-cash-items	815.4	-980.3	-312.3	21.1	93	-99.2	19.6	66.5	5.7	44.8	21.9	86.1	-367.8	-120.1	42.6	37.7	-22.6	12.7	14.5	102	4.9	-8.6	0.3	0.9	0.2	-10.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-348.1	-491.6	-600.7	-479.6	-293.1	-773.1	-185.5	-411.5	-400.1	-106.1	-190.4	-241.8	-88.8	-72.7	-79.1	-56.7	-258.3	-286.9	-119.4	-49.1	-57.9	-89.4	-88.7	-52.5	-241	-16.5
cash-flows.row.acquisitions-net	0.4	0	20.4	-28.1	0	778.4	0.2	412.1	-0.1	0	0	241.9	0	73.2	19.7	0	0	0	0	0	0	0	0	0	241	0.1
cash-flows.row.purchases-of-investments	-238.1	-1153.5	-844.5	-510	-438	-518	-1244	-738.9	-1.8	0	-34.4	-17.2	0	-36.1	79.4	0	0	-9.7	0	-6.9	-161.9	-9.5	0	0	-2.5	-28.9
cash-flows.row.sales-maturities-of-investments	240.6	1992.8	1458.9	399.9	579.1	536	1321.2	312.1	48.7	0	0	14.1	456.2	143.9	51.3	0	84.8	0	0	0	0	0	0	0	0.5	0
cash-flows.row.other-investing-activites	0	-3.7	0	1.2	-0.4	-773.1	1.7	-411.5	-225.2	0	56.4	-241.8	0.1	-72.7	-79.1	0	0	0	0	0	0	0.5	0	-1	-241	4.2
cash-flows.row.net-cash-used-for-investing-activites	-345.2	344	34.1	-616.6	-152.5	-749.7	-106.5	-837.9	-578.4	-106	-168.3	-244.9	367.4	35.7	-7.7	-56.7	-173.5	-296.6	-119.4	-55.9	-219.8	-98.4	-88.7	-53.5	-242.9	-41.1
cash-flows.row.debt-repayment	-150	0	0	-400	-851.3	-501.3	-1019.3	-1396.9	-359.3	-362.3	-98.3	-102.3	-171.8	-275.5	-332.5	-324.6	-181.7	-458.4	-195.5	-170.2	-82	-97	-5.5	-20.6	-41.7	-101.4
cash-flows.row.common-stock-issued	0	0	77.4	59.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	-59.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-495.9	-1095.8	-425	-413.7	-427.4	-355.7	-299.9	-271.8	-247.1	-222.6	-181.2	-169.9	-16.6	-22.5	-32.2	-23.7	-19.2	-16	-18.2	-19.3	-86.7	-1.5	-32.7	-1.1	-4.4	-6.9
cash-flows.row.other-financing-activites	422	-188.3	-348	333	324.5	649.3	561	1804.2	900.3	470.9	318.6	204.4	63	118	234.3	321.7	254.1	593.6	254.9	242.5	328	177.9	5.3	3.8	305.6	336.9
cash-flows.row.net-cash-used-provided-by-financing-activities	-224	-1284.1	-695.6	-480.8	-954.2	-207.7	-758.2	135.5	293.9	-114	39	-67.8	-125.4	-180	-130.4	-26.5	53.2	119.2	41.2	53	159.3	79.5	-32.9	-17.9	259.5	228.6
cash-flows.row.effect-of-forex-changes-on-cash	0.6	0	0	0	0	0	0	0	0.3	0	-0.3	-1	-5.7	0	0	-35.6	52.6	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	316.1	-77	473	94.9	45.5	-80.5	96.5	23.4	10.3	-14.2	91.5	-119.4	181.2	16.1	28.1	-26.5	53.2	-19.4	14	10.2	-14.9	13	-3.9	-42.3	-78.5	-29.5
cash-flows.row.cash-at-end-of-period	1104.2	788.1	865	392	297.1	251.7	332.1	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	-26.5	53.2	8.9	28.3	14.3	4.1	19	6.1	9.8	54.1	132.6
cash-flows.row.cash-at-beginning-of-period	788.1	865	392	297.1	251.7	332.1	235.6	212.2	201.9	216.1	124.6	244	62.8	46.7	18.6	0	0	28.3	14.3	4.1	19	6	10	52.1	132.6	162.1
cash-flows.row.operating-cash-flow	884.7	863.1	1134.5	1192.3	1152.2	876.9	961.2	725.8	294.6	205.9	221.1	194.3	-55.1	160.4	166.2	92.3	120.9	158	92.2	13.2	45.5	32	117.7	29.1	-95.1	-217
cash-flows.row.capital-expenditure	-348.1	-491.6	-600.7	-479.6	-293.1	-773.1	-185.5	-411.5	-400.1	-106.1	-190.4	-241.8	-88.8	-72.7	-79.1	-56.7	-258.3	-286.9	-119.4	-49.1	-57.9	-89.4	-88.7	-52.5	-241	-16.5
cash-flows.row.free-cash-flow	536.6	371.5	533.8	712.7	859	103.9	775.7	314.2	-105.5	99.8	30.7	-47.5	-143.9	87.7	87.1	35.6	-137.4	-128.9	-27.2	-35.9	-12.4	-57.4	29	-23.3	-336.1	-233.5

損益計算書の行

Tonghua Dongbao Pharmaceutical Co., Ltd. の売上は前期比 NaN% の変化。600867.SS の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	3061.4	2778.5	3267.9	2892.2	2777.1	2692.9	2545.3	2040.4	1669.3	1451.3	1204.2	991.5	784.5	637.8	573.9	551	470	401.6	329.7	307.8	298.7	280.6	205.9	199.1	219.7	218.9	205.4	223.8	212.2	132
income-statement-row.row.cost-of-revenue	689.7	617.5	575.7	588.4	721.5	745	644.5	491.9	412.9	452	385.4	357.3	295.4	243.4	245.2	262.2	242.2	217.7	192.3	168.5	151.1	138.1	116.8	103.3	79.8	59.7	57.3	62.8	49.5	0
income-statement-row.row.gross-profit	2371.6	2160.9	2692.2	2303.8	2055.6	1947.9	1900.9	1548.5	1256.4	999.3	818.8	634.2	489.1	394.3	328.7	288.9	227.8	184	137.4	139.3	147.6	142.4	89.1	95.8	139.9	159.2	148.1	161	162.7	132
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-5.6	145.3	171.8	99	121.9	-15.5	-13.2	20.2	1.3	3.1	6.2	18.2	4.1	8.5	27.8	7.3	11.7	3.4	2.8	3.3	1.3	2.4	5.2	11.5	23.9	17.3	0.3	0.9	0.5	0.2
income-statement-row.row.operating-expenses	1101.1	1270.4	1420.7	1163.9	1101.4	957.8	897.8	742.2	683.7	635.5	592.6	500.5	434.4	324	232.6	192.2	174.9	124.9	102.4	173.5	106.2	96.1	60.6	51.5	70.2	65.3	50.6	47.5	61.9	0.2
income-statement-row.row.cost-and-expenses	1790.9	1887.9	1996.3	1752.2	1822.9	1702.8	1542.3	1234	1096.6	1087.5	978	857.8	729.8	567.4	477.8	454.3	417.1	342.5	294.7	342	257.3	234.3	177.4	154.7	150	125	107.9	110.3	111.4	0.2
income-statement-row.row.interest-income	-11.7	13.9	8.1	4.7	7.2	3.3	1.6	0.8	2.1	0.7	0.8	0.9	0.4	0.1	0.1	0.1	0.1	0.8	2.2	2.4	2.2	1.8	1.4	7.2	0	0	0	0	0	0
income-statement-row.row.interest-expense	4.5	0.3	0.2	10.2	20.6	13.5	15.5	44.6	18.2	27.5	17.6	13.8	16.6	22.5	32.2	23.7	19.3	16	16.2	17.4	6	0.7	0.3	0.3	-6.2	-2.4	-7.4	-3.6	-0.3	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	6.2	0.6	-14.8	-72.5	-15.4	-12.6	-30	-47.4	-2.2	-40	-14.5	-66.7	372.2	128.5	-15.7	-31.3	34.1	-40.5	-14.4	-40	1.9	5.8	3	17.5	21.9	28.8	7.2	3.6	-1.5	-59.7
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-5.6	145.3	171.8	99	121.9	-15.5	-13.2	20.2	1.3	3.1	6.2	18.2	4.1	8.5	27.8	7.3	11.7	3.4	2.8	3.3	1.3	2.4	5.2	11.5	23.9	17.3	0.3	0.9	0.5	0.2
income-statement-row.row.total-operating-expenses	6.2	0.6	-14.8	-72.5	-15.4	-12.6	-30	-47.4	-2.2	-40	-14.5	-66.7	372.2	128.5	-15.7	-31.3	34.1	-40.5	-14.4	-40	1.9	5.8	3	17.5	21.9	28.8	7.2	3.6	-1.5	-59.7
income-statement-row.row.interest-expense	4.5	0.3	0.2	10.2	20.6	13.5	15.5	44.6	18.2	27.5	17.6	13.8	16.6	22.5	32.2	23.7	19.3	16	16.2	17.4	6	0.7	0.3	0.3	-6.2	-2.4	-7.4	-3.6	-0.3	0
income-statement-row.row.depreciation-and-amortization	207.1	156.6	156.1	84.9	171.6	172	166.5	160.4	130.8	112.8	108.3	107.6	106.7	103.5	89	72.8	69	64	57.9	48.9	46.9	37.9	27.1	26.5	30.9	17.2	-7.8	-4.6	-2.6	59.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1270.5	1828.9	1549.3	1180.7	967.8	993	986.2	738.9	569.2	327.4	206.6	49	423.1	190.4	52.7	58.3	75.5	22.6	22.3	-71.1	45.6	52.6	36.9	55.1	84.5	105.7	105.3	118.1	103.4	72.1
income-statement-row.row.income-before-tax	1276.7	1829.5	1534.5	1108.1	952.5	977.5	973	758.9	570.5	323.8	211.8	67.1	426.9	198.9	80.4	65.4	87	22.3	22.8	-70.9	45.1	53.5	36.8	64.2	100	122.8	105.2	118	101.6	72.2
income-statement-row.row.income-tax-expense	198	247.7	225.9	177.8	142.9	138.6	132.9	119.7	80.5	47.3	32.3	7.4	63.9	25.5	12.7	20.9	11.4	9	4.8	3.9	6.9	9.2	5.7	16.2	28.4	32.2	14.5	36.5	33.5	23.8
income-statement-row.row.net-income	1167.8	1581.9	1308.3	929.9	811.2	838.6	836.6	640.9	493	279.8	183.9	62.7	364	178.4	73.7	46.8	77.4	12.1	16.2	-78.2	36.1	40	29.3	46.3	67.6	92.6	90.6	81.5	68.1	48.4